Use Able AI chat for product recommendations
  • Featured Product
  • KD/KO Validated

GM-CSF Polyclonal antibody

GM-CSF Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human and More (3)

Applications

WB, IHC, IF, ELISA

CSF2, Colony stimulating factor, Colony Stimulating Factor 2, Colony-stimulating factor, CSF

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for GM-CSF in ?

Tested Applications

Positive WB detected inNK-92 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

17762-1-AP targets GM-CSF in WB, IHC, IF, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman, mouse, rat, hamster
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag12142

Product name: Recombinant human CSF2 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 1-144 aa of BC108724

Sequence: MWLQSLLLLGTVACSISAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE

Predict reactive species
Full Name colony stimulating factor 2 (granulocyte-macrophage)
Calculated Molecular Weight 144 aa, 16 kDa
Observed Molecular Weight15kDa,18 kDa ,22 kDa
GenBank Accession NumberBC108724
Gene Symbol GM-CSF
Gene ID (NCBI) 1437
RRIDAB_2276718
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDP04141
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Granulocyte-macrophage colony-stimulating factor (GM-CSF), also known as colony-stimulating factor 2 (CSF2), is a monomeric glycoprotein secreted by macrophages, T cells, mast cells, natural killer cells, endothelial cells and fibroblasts. GM-CSF is a hematopoietic growth factor that stimulates the development of early erythroid megakaryocytic and eosinophilic progenitor cells (PMID 2990035). GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes (PMID 3021817, 2984574, 6390681).

Protocols

Product Specific Protocols
WB protocol for GM-CSF antibody 17762-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

17762-1-AP is a GM-CSF antibody with 43 total citations. Publications appear in high-impact journals including Nature Nanotechnology, Journal of Experimental Medicine, Oncogene, Journal of Hematology & Oncology, Frontiers in Immunology, and others. Research fields span tumor immunology, inflammatory bowel disease, cardiac fibrosis, nephrology, neuroinflammation, reproductive medicine, and infectious disease, with applications primarily in WB, IHC, and IF.

SpeciesApplicationTitle

J Hematol Oncol

FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion

Authors - Zeda Zhao
mouseWB,IHC

Nat Nanotechnol

A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy

Authors - Yanqin Zhang
mouseWB

Gut Microbes

FMT rescues mice from DSS-induced colitis in a STING-dependent manner

Authors - Dan Pu
WB

Adv Sci (Weinh)

Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy

Authors - Panpan Ji
humanWB,IHC

Cancer Lett

HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma.

Authors - Haotian Wang
humanIHC

J Immunother Cancer

Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial

Authors - Zhichao Tan
Loading...
||
New chat

Able™

正在加载,请稍候...